Cannabis Bioscience International Holdings, Inc. 10-Q/A

Item 5. Other Information.   Insider Trading Arrangements and Related Disclosure   During the three months ended February 28, 2025, none of our directors or officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.   22 Item 6. Exhibits.   Exhibit Number   Title         31   Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer and Principal Accounting Officer * 32   Section 1350 Certification of Principal Executive Officer and Principal Accounting Officer * 101.INS*   Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) 101.SCH*   Inline XBRL Taxonomy Extension Schema Document 101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document 104**   Cover Page Interactive Data File (embedded within the Inline XBRL document) ____________ * Filed herewith 23 SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this amended report to be signed on its behalf by the undersigned thereunto duly authorized.       CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.     Date: May 9, 2025 By:  /s/ Dante Picazo     Dante Picazo Principal Executive Officer and Principal Accounting Officer 24